Updating results

477 results

Sort: Relevance | Date

Osteoarthritis

Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart

NICE Pathway Published February 2014 Last updated August 2019

Hearing loss in adults (QS185)

This quality standard covers assessing and managing hearing loss in adults (aged 18 and over). It includes people presenting with hearing loss for the first time in adulthood whether it started in adulthood or earlier. It describes high-quality care in priority areas for improvement.

Quality standard Published July 2019

Chronic kidney disease

Everything NICE has said on chronic kidney disease (renal failure) in an interactive flowchart

NICE Pathway Published May 2011 Last updated September 2019

Fertility, pregnancy and childbirth

Everything NICE has said on fertility, pregnancy and childbirth in an interactive flowchart

NICE Pathway Published September 2016 Last updated September 2019

Caesarean section

Everything NICE has said on caesarean section in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Fertility

Everything NICE has said on assessing and treating people with fertility problems in an interactive flowchart

NICE Pathway Published February 2013 Last updated September 2019

Antenatal care for uncomplicated pregnancies

Everything NICE has said on antenatal care for healthy women with uncomplicated pregnancies in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Chronic heart failure

Everything NICE has said on diagnosing and managing chronic heart failure in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated September 2019

Intrapartum care for women with obstetric complications

Everything NICE has said on intrapartum care for women with obstetric complications in an interactive flowchart

NICE Pathway Published March 2019 Last updated September 2019

Learning disability: care and support of people growing older (QS187)

This quality standard covers identifying, assessing and regularly reviewing the care and support needs of people with a learning disability as they grow older. People with a learning disability have many of the same age-related health and social care needs as other people, but this quality standard focuses on the specific challenges associated with their learning disability. It describes high-quality care in priority areas for improvement.

Quality standard Published July 2019

Safe midwifery staffing for maternity settings

Everything NICE has said on safe midwifery staffing requirements for maternity settings in an interactive flowchart

NICE Pathway Published February 2015 Last updated September 2019

Ear, nose and throat conditions

Everything NICE has said on ear, nose and throat conditions in an interactive flowchart

NICE Pathway Published November 2013 Last updated September 2019

Service user experience in adult mental health services

Everything NICE has said on improving the experience of care for people using adult NHS mental health services in an interactive flowchart

NICE Pathway Published March 2012 Last updated September 2019

Self-harm

Everything NICE has said on assessing and managing self-harm in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Endocrine cancers

Everything NICE has said on endocrine cancers in an interactive flowchart

NICE Pathway Published March 2018 Last updated September 2019

Suicide prevention

Everything NICE has said on preventing suicide in community and residential custodial and detention settings in an interactive flowchart

NICE Pathway Published September 2018 Last updated September 2019

Multiple pregnancy: twin and triplet pregnancies (QS46)

This quality standard covers the additional antenatal care for women who are pregnant with twins or triplets that is offered alongside routine antenatal care. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2013 Last updated September 2019

Urinary tract infections

Everything NICE has said on diagnosing, treating and managing urinary tract infections including lower (cystitis), upper (acute pyelonephritis) and recurrent UTIs in people with or without a catheter in an interactive flowchart

NICE Pathway Published August 2012 Last updated September 2019

Twin and triplet pregnancy

Everything NICE has said on managing twin and triplet pregnancies in the antenatal and intrapartum period in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Prostatitis – antimicrobial prescribing

Everything NICE has said on antimicrobial prescribing for acute prostatitis in an interactive flowchart.

NICE Pathway Published October 2018 Last updated September 2019

Tuberculosis

Everything NICE has said on preventing, diagnosing and managing latent and active tuberculosis in an interactive flowchart

NICE Pathway Published January 2012 Last updated September 2019

Chronic obstructive pulmonary disease

Everything NICE has said on diagnosing and managing chronic obstructive pulmonary disease in people aged 16 and over in an interactive flowchart

NICE Pathway Published May 2011 Last updated September 2019

Bronchiectasis (non-cystic fibrosis) – antimicrobial prescribing

Everything NICE has said on antimicrobial prescribing for managing and preventing an acute exacerbation of bronchiectasis (non-cystic fibrosis) in an interactive flowchart

NICE Pathway Published December 2018 Last updated September 2019

Head injury

Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart

NICE Pathway Published January 2014 Last updated September 2019

Attention deficit hyperactivity disorder

Everything NICE has said on diagnosing and managing attention deficit hyperactivity disorder (ADHD) in children, young people and adults in an interactive flowchart

NICE Pathway Published July 2013 Last updated September 2019

Lung cancer

Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

NICE Pathway Published March 2012 Last updated September 2019

Pneumonia

Everything NICE has said on diagnosing and managing community- and hospital-acquired pneumonia in an interactive flowchart

NICE Pathway Published December 2014 Last updated September 2019

Lung cancer in adults (QS17)

This quality standard covers diagnosing and managing lung cancer in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.

Quality standard Published March 2012 Last updated September 2019

Acutely ill patients in hospital

Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart

NICE Pathway Published August 2012 Last updated September 2019

Suicide prevention (QS189)

This quality standard covers ways to reduce suicide and help people bereaved or affected by suicide. It describes high-quality care in priority areas for improvement.

Quality standard Published September 2019

Coexisting severe mental illness and substance misuse (QS188)

This quality standard covers the assessment, management and care provided for people aged 14 and over who have coexisting severe mental illness and substance misuse. It describes high-quality care in priority areas for improvement.

Quality standard Published August 2019

Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality (TA322)

Evidence-based recommendations on lenalidomide (Revlimid) for myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality

Technology appraisal guidance Published September 2014 Last updated June 2019

Lenalidomide for the treatment of multiple myeloma in people who have received at least 2 prior therapies (TA171)

Evidence-based recommendations on lenalidomide (Revlimid) for the treatment of multiple myeloma in people who have received at least 2 prior therapies

Technology appraisal guidance Published June 2009 Last updated June 2019

Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal) (TA594)

NICE is unable to make a recommendation about the use in the NHS of brentuximab vedotin (Adcetris) for untreated advanced Hodgkin lymphoma in adults

Technology appraisal guidance Published August 2019

Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancer (TA595)

Evidence-based recommendations on dacomitinib (Vizimpro) for locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (NSCLC) in adults

Technology appraisal guidance Published August 2019

Ribociclib with fulvestrant for treating hormone receptor-positive, HER2-negative, advanced breast cancer (TA593)

Evidence-based recommendations on ribociclib (Kisqali) for hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer in adults

Technology appraisal guidance Published August 2019

Risankizumab for treating moderate to severe plaque psoriasis (TA596)

Evidence-based recommendations on risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults

Technology appraisal guidance Published August 2019

Bisphosphonates for treating osteoporosis (TA464)

Evidence-based recommendations on bisphosphonates (alendronic acid; ibandronic acid; risedronate sodium; zoledronic acid) for treating osteoporosis in adults

Technology appraisal guidance Published August 2017 Last updated July 2019

Lenalidomide plus dexamethasone for previously untreated multiple myeloma (TA587)

Evidence-based recommendations on lenalidomide (Revlimid) plus dexamethasone for previously untreated multiple myeloma in adults

Technology appraisal guidance Published June 2019

Lenalidomide plus dexamethasone for multiple myeloma after 1 treatment with bortezomib (TA586)

Evidence-based recommendations on lenalidomide (Revlimid) plus dexamethasone for multiple myeloma after 1 treatment with bortezomib in adults

Technology appraisal guidance Published June 2019

Dapagliflozin with insulin for treating type 1 diabetes (TA597)

Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for type 1 diabetes not controlled by insulin therapy alone in adults with a BMI of at

Technology appraisal guidance Published August 2019

Nusinersen for treating spinal muscular atrophy (TA588)

Evidence-based recommendations on nusinersen (Spinraza) for treating spinal muscular atrophy in children and adults

Technology appraisal guidance Published July 2019

Letermovir for preventing cytomegalovirus disease after a stem cell transplant (TA591)

Evidence-based recommendations on letermovir (Prevymis) for preventing cytomegalovirus (CMV) disease after a stem cell transplant in adults

Technology appraisal guidance Published July 2019

Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis (TA590)

Evidence-based recommendations on fluocinolone acetonide intravitreal implant (Iluvien) for treating recurrent non-infectious uveitis in adults

Technology appraisal guidance Published July 2019

Benralizumab for treating severe eosinophilic asthma (TA565)

Evidence-based recommendations on benralizumab (Fasenra) for treating severe eosinophilic asthma (SEA; elevated levels of eosinophils in blood) in adults

Technology appraisal guidance Published March 2019 Last updated September 2019

Sodium zirconium cyclosilicate for treating hyperkalaemia (TA599)

Evidence-based recommendations on sodium zirconium cyclosilicate (Lokelma) for treating hyperkalaemia (elevated blood potassium levels) in adults

Technology appraisal guidance Published September 2019

Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer (TA600)

Evidence-based recommendations on pembrolizumab (Keytruda) with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer (NSCLC)

Technology appraisal guidance Published September 2019

Cemiplimab for treating metastatic or locally advanced cutaneous squamous cell carcinoma (TA592)

Evidence-based recommendations on cemiplimab (Libtayo) for treating locally advanced or metastatic cutaneous squamous cell carcinoma (CSCC) in adults

Technology appraisal guidance Published August 2019

Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy (TA598)

Evidence-based recommendations on olaparib (Lynparza) for treating BRCA mutation-positive, advanced ovarian, fallopian tube or primary peritoneal cancer

Technology appraisal guidance Published August 2019